Stock listing
Aditxt, Inc.
Selected listing: ADTX · NASDAQ · USD · US
Aditxt, Inc. (NASDAQ:ADTX), Health Technology. Latest release Jun 9, 2026: Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150…
- Ticker
- NASDAQ:ADTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Aditxt, Inc.
The company focuses on innovative solutions in the healthcare sector. Aditxt aims to enhance immune health and improve patient outcomes through its proprietary technologies.
Latest news from Aditxt, Inc.
Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million
June 9, 2026
Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selection
June 8, 2026
Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer, Founder and Former CEO of $1B NYSE Enterprise Which Delivered 8.5% Dividends to Shareholders
June 2, 2026
Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders
June 1, 2026
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026
May 13, 2026